Subcutaneous administration of isatuximab in patients with multiple myeloma by an on-body delivery system: results of a nurse survey
Our findings show a high level of confidence among nurses in SC Isa administration via OBDS, due to the ease of use, tolerability, and time savings achieved with hands-free OBDS injections. Our findings suggest applicability of the OBDS for convenient SC Isa administration to MM patients in routine clinical practice.
Authors
- Paúl Cordero (ORCID: https://orcid.org/0000-0001-9236-2268)
- Florence Suzan
- Connie Barlas
- Nuria Sánchez Avello
- Paula Calvo Pajares
Institutions
- Epworth Hospital (AU)
- Sanofi (France) (FR)
- Instituto de Investigación Marqués de Valdecilla (ES)
- Sanofi (United Kingdom) (GB)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-06-18
- DOI
- https://doi.org/10.3389/fonc.2025.1547108
- Citations
- 5
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 8.85
Funders
- Sanofi